| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
1,095,971,000 |
| Market
Cap: |
15.14(B) |
| Last
Volume: |
10,278,701 |
Avg
Vol: |
10,598,169 |
| 52
Week Range: |
$7.2 - $14.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
677,343 |
677,343 |
767,191 |
1,433,490 |
| Total Sell Value |
$8,974,605 |
$8,974,605 |
$9,773,842 |
$16,030,825 |
| Total People Sold |
8 |
8 |
8 |
11 |
| Total Sell Transactions |
14 |
14 |
17 |
32 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shani Eli |
EVP,Global Marketing&Portfolio |
• – – |
2022-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,581 |
19,741 |
|
- |
|
| Stark David Matthew |
Exec. VP Chief Legal Officer |
• – – |
2022-07-28 |
4 |
AS |
$9.04 |
$525,590 |
D/D |
(58,163) |
2,974 |
|
-12% |
|
| Lieberman Gerald M |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,479 |
69,107 |
|
- |
|
| Halfon Jean Michel |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,479 |
63,707 |
|
- |
|
| Vergis Janet S. |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,479 |
27,147 |
|
- |
|
| Satchi-Fainaro Ronit |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,479 |
51,359 |
|
- |
|
| Nisen Perry |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,479 |
58,765 |
|
- |
|
| Elstein Amir |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,479 |
2,057,413 |
|
- |
|
| Crane Rosemary A |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,479 |
66,697 |
|
- |
|
| Mignone Roberto |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,479 |
58,765 |
|
- |
|
| Peres Nechemia Jacob |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,479 |
58,765 |
|
- |
|
| Barer Sol J |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,791 |
343,354 |
|
- |
|
| Fridriksdottir Hafrun |
Executive VP, Global R&D |
• – – |
2022-05-17 |
4 |
S |
$8.22 |
$1,068,067 |
D/D |
(130,000) |
1,387 |
|
8% |
|
| Drape Eric |
Executive VP Global Operations |
• – – |
2022-03-07 |
4 |
AS |
$7.37 |
$83,494 |
D/D |
(11,334) |
78,072 |
|
-4% |
|
| Stark David Matthew |
Exec. VP Chief Legal Officer |
• – – |
2022-03-07 |
4 |
AS |
$7.37 |
$66,720 |
D/D |
(9,057) |
61,137 |
|
-4% |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2022-03-07 |
4 |
AS |
$7.37 |
$166,311 |
D/D |
(22,576) |
43,182 |
|
-4% |
|
| Fridriksdottir Hafrun |
Executive VP, Global R&D |
• – – |
2022-03-07 |
4 |
AS |
$7.37 |
$65,866 |
D/D |
(8,941) |
126,087 |
|
-4% |
|
| Dethlefs Sven |
EVP, North America Commercial |
• – – |
2022-03-07 |
4 |
AS |
$7.37 |
$51,515 |
D/D |
(6,993) |
165,381 |
|
-4% |
|
| Drape Eric |
Executive VP Global Operations |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,576 |
89,406 |
|
- |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,387 |
64,876 |
|
- |
|
| Weiss Amir |
Chief Accounting Officer |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,564 |
24,558 |
|
- |
|
| Sabag Mark |
EVP, International Markets |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,764 |
177,645 |
|
- |
|
| Shani Eli |
EVP,Global Marketing&Portfolio |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,896 |
18,160 |
|
- |
|
| Stark David Matthew |
Exec. VP Chief Legal Officer |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,199 |
70,194 |
|
- |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,576 |
65,758 |
|
- |
|
521 Records found
|
|
Page 5 of 21 |
|
|
0.56 (4.23%) 
